As used in this chapter, unless the context otherwise requires:
(1) “Board” means the board of pharmacy created by § 63-10-301;
(2) “Commissioner” means the commissioner of health;
(3) “Controlled substance analogues” is defined as in § 39-17-454;
(4) “Controlled substances” is defined as in § 39-17-402;
(5) “Director” means the director of the board of pharmacy elected pursuant to § 63-10-303;
(6) “Legend drugs” is defined as in § 53-10-101; and
(7) “Person” means an individual, corporation, government or governmental subdivision or agency, business trust, estate, trust, partnership or association, or any other legal entity.